Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Torrent-JB Chemicals Rs 25,689 Crore Merger Under CCI Lens Over Monopoly Concerns

Susmita Roy14 Oct 2025 5:57 PM IST

New Delhi: The Competition Commission of India (CCI) has expressed serious concerns over the proposed merger between Torrent Pharmaceuticals and JB...

Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tablet

Susmita Roy14 Oct 2025 5:23 PM IST

New Delhi: Alkem Laboratories has got the go-ahead from the Subject Expert Committee (SEC), functioning under the Central Drug Standard Control...

Sun Pharma Gets CDSCO Panel Approval to Conduct Phase III Study of Oral Semaglutide

Sun Pharma Wins Interim Relief in NAXDOM Trademark Row, Delhi HC Bars Alenvision's NEXADOM Drug

Susmita Roy13 Oct 2025 9:34 PM IST

New Delhi: The Delhi High Court has granted an ex-parte ad-interim injunction in favour of Sun Pharmaceutical Medicare, a subsidiary of Sun...

Kerala RCC Blacklists Globela Pharma After Brain Cancer Drug Found in Wrong Packaging

Susmita Roy12 Oct 2025 2:00 PM IST

New Delhi: In a serious lapse that could have endangered patient safety, the Regional Cancer Centre (RCC) in Thiruvananthapuram has barred Globela...

Ongoing Sale of Covid-Era Liposomal Amphotericin B Challenged, SC Seeks Response from Top Pharma Firms, DCGI

Susmita Roy11 Oct 2025 11:39 PM IST

New Delhi: The Supreme Court has sought responses from the Union of India, the Drug Controller General of India (DCGI), and several leading...

CDSCO Orders Nationwide Audit of Cough Syrup Makers After Fatal Toxic Syrup Scare

Susmita Roy11 Oct 2025 9:53 PM IST

New Delhi: Amid a chilling surge in child deaths linked to contaminated cough syrups, the Central Drugs Standard Control Organization (CDSCO) has...

Novo Nordisk gets UK nod for Concizumab to prevent bleeding episodes frequency

CDSCO Panel seeks clarifications from Novo Nordisk on IcoSema phase IIIb clinical study protocol

Susmita Roy11 Oct 2025 9:46 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has opined that Novo Nordisk India should...

Breaking News: Delhi HC Stays FSSAI Order On ORS Labels, Gives Interim Relief to Kenvues ORSL

Delhi HC Dismisses Roche Appeal, Allows Natco to Continue Selling Generic Risdiplam for Spinal Muscular Atrophy

Susmita Roy11 Oct 2025 9:41 PM IST

New Delhi: The Delhi High Court has dismissed an appeal filed by Swiss drug major F. Hoffmann-La Roche AG and its Indian arm, challenging the order of...

Pulse Pharma Gets CDSCO Panel Nod to Manufacture, Market Aripiprazole Oral Solution

No Entry Without Notice: CDSCO Directs All Drug Shipments Through Notified Ports via ICEGATE

Susmita Roy10 Oct 2025 4:59 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a directive reminding stakeholders that the import of drugs into India...

CDSCO Panel Rejects Troikaa Pharmas High-Strength Paracetamol Injection Citing Safety Concerns

Fludrocortisone 0.2 mg Study Rejected by CDSCO Panel Over Potential Adverse Effects

Susmita Roy9 Oct 2025 11:02 PM IST

New Delhi: Noting the possible risk of expected adverse effects in healthy subjects, the Subject Expert Committee (SEC), functioning under the Central...

SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar

Unequal Trials in New Drug Approvals: CDSCO Seeks Feedback for Policy Reform

Susmita Roy9 Oct 2025 9:17 PM IST

New Delhi: With an aim to address the existing disparity between the first applicant who conducts full-scale clinical and bioequivalence (BE) studies...

After Cough Syrup Deaths, IPC Issues Toolkit to Curb DEG, EG Contamination in Liquid Formulations

After Cough Syrup Deaths, CDSCO Tightens Oversight on Drug Testing Compliance

Susmita Roy8 Oct 2025 8:06 PM IST

New Delhi: In the wake of the tragic child deaths in Chhindwara, Madhya Pradesh, allegedly linked to contaminated cough syrups, the Central Drugs...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok